Candida Infections: Outcome and Attributable ICU Costs in Critically Ill Patients
- 18 September 2000
- journal article
- Published by SAGE Publications in Journal of Intensive Care Medicine
- Vol. 15 (5) , 255-261
- https://doi.org/10.1046/j.1525-1489.2000.00255.x
Abstract
No abstract availableThis publication has 20 references indexed in Scilit:
- Epidemiology of Nosocomial Fungal Infections, with Emphasis on Candida SpeciesClinical Infectious Diseases, 1995
- A Randomized Trial Comparing Fluconazole with Clotrimazole Troches for the Prevention of Fungal Infections in Patients with Advanced Human Immunodeficiency Virus InfectionNew England Journal of Medicine, 1995
- Nosocomial bloodstream infection in critically ill patients. Excess length of stay, extra costs, and attributable mortalityPublished by American Medical Association (AMA) ,1994
- The cost of infection in surgical patients: a case-control studyJournal of Hospital Infection, 1993
- Nosocomial pneumonia in ventilated patients: A cohort study evaluating attributable mortality and hospital stayThe American Journal of Medicine, 1993
- A Controlled Trial of Fluconazole to Prevent Fungal Infections in Patients Undergoing Bone Marrow TransplantationNew England Journal of Medicine, 1992
- Major trends in the microbial etiology of nosocomial infectionThe American Journal of Medicine, 1991
- Hospital-acquired candidemia. The attributable mortality and excess length of stayArchives of internal medicine (1960), 1988
- The financial incentive for hospitals to prevent nosocomial infections under the prospective payment system. An empirical determination from a nationally representative sampleJAMA, 1987
- Effect of intensive care unit nosomial pneumonia on duration of stay and mortalityAmerican Journal of Infection Control, 1984